Publikationen, an denen er mitarbeitet Ferran Nadeu (18)

2024

  1. Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma

    Blood Cancer Journal, Vol. 14, Núm. 1

  2. MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma

    Blood Cancer Journal, Vol. 14, Núm. 1

  3. Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL

    HemaSphere, Vol. 8, Núm. 10

2023

  1. Intravascular Large B-Cell Lymphoma Genomic Profile Is Characterized by Alterations in Genes Regulating NF-κB and Immune Checkpoints

    American Journal of Surgical Pathology, Vol. 47, Núm. 2, pp. 202-211

  2. MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma

    British Journal of Haematology, Vol. 196, Núm. 3, pp. 589-598

2021

  1. MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma

    Haematologica, Vol. 106, Núm. 10, pp. 2682-2693

2020

  1. Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma

    Haematologica

  2. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma

    Blood, Vol. 135, Núm. 4, pp. 274-286

2019

  1. Burkitt-like lymphoma with 11q aberration: A germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma

    Haematologica, Vol. 104, Núm. 9, pp. 1822-1829

2018

  1. A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration

    Modern Pathology, Vol. 31, Núm. 5, pp. 732-743

  2. Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia

    Leukemia, Vol. 32, Núm. 3, pp. 645-653

  3. Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets

    Leukemia, Vol. 32, Núm. 3, pp. 675-684

2017

  1. Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation

    Blood, Vol. 130, Núm. 3, pp. 323-327

2016

  1. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia

    Blood, Vol. 127, Núm. 17, pp. 2122-2130

  2. Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene

    Blood, Vol. 128, Núm. 8, pp. 1101-1111

  3. NOTCH1, TP53, and MAP2K1 mutations in splenic diffuse red pulp small B-cell lymphoma are associated with progressive disease

    American Journal of Surgical Pathology, Vol. 40, Núm. 2, pp. 192-201

2013

  1. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 45, pp. 18250-18255